Skip to main content
Ingredients/Amino acid/L-Ornithine L-Aspartate (LOLA)

L-Ornithine L-Aspartate (LOLA).

Strength pending.The research strength is not set yet.

Helps your liver clear exercise byproducts A one to one salt of ornithine and aspartate that feeds both nitrogen entry points of the urea cycle, which is how the body moves ammonia nitrogen toward urea.

3,000 to 6,000mgDaily amount241Studies read

Reviewed March 2026

LOAmino acid
L-Ornithine L-Aspartate (LOLA)IngredientMD
Category
Amino acid

Also filed under
Ammonia detoxLiver supportExercise recovery

What L-Ornithine L-Aspartate (LOLA) is, and what it does.

Does it work
Suits people who drink socially and endurance athletes interested in nitrogen handling. Most research sits in hospital settings, so everyday use rests on the mechanism.
How much to take
Start with 6,000mg to 9,000mg a day, the maintenance band on record, split across the day with food. Studies have run to 18,000mg as a research condition.
Time to feel it
Ammonia handling shifts within hours, but that is a blood measurement. Anything you would notice sits further out, across days of steady daily use.
The first dose
Ammonia handling shifts within hours, and that is a blood measurement. Day one brings no sensation you could point to.
With regular use
Weeks of daily use keep both nitrogen entry points of the urea cycle stocked. The read-out is an ammonia figure on a panel rather than a change in how a day feels.
How well tolerated
Well tolerated, with mild nausea the most reported effect at higher amounts. Check with your clinician first if you have liver or kidney concerns, or are pregnant.
How it feels
Quiet. It works upstream in nitrogen handling, so the signal turns up on a blood panel rather than as a sensation you can point to.
The overlooked benefit
Ornithine is also the doorway into polyamine synthesis through ornithine decarboxylase, the pathway that cell growth and tissue repair run on.

3,000 to 6,000mg a day is where L-Ornithine L-Aspartate (LOLA) works.

How much to take a dayMedium confidence
3,000 to 6,000mg
Daily maintenanceThe everyday amount, and where most daily supplements sit. This is the one you take month after month.
10,000mgClinical territory. Trials run high on purpose, for a set number of weeks, against one measured outcome. Impressive to hit, and not what a daily product is for.
Above 20,000mgPast what the research covers. More capsules rather than more effect.
MORE EFFECT ↑06,000mg10,000mg plateauDAILY DOSE →
The shaded band is where the dosing trials landed.

Source: Bai 2009 blood pressure meta + Dong 2011 review

The proof, claim by claim.

These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.

L-Ornithine L-Aspartate (LOLA) has emerging evidence. Based on 241+ studies.

  • Blood ammonia clearanceMeta-analysis
  • Urea cycle substrate supplyNarrative review
  • Muscle glutamine formation from circulating nitrogenNarrative review
  • Exercise-related ammonia and fatigue markersRandomised trial
  • Polyamine synthesis and tissue repair signallingAnimal study
PubMedCochraneClinicalTrials.govNIH ODSSUPP.AI241 studies readLabs test. IngredientMD verifies.PubMedCochraneClinicalTrials.govNIH ODSSUPP.AI241 studies readLabs test. IngredientMD verifies.

Questions people ask about L-Ornithine L-Aspartate (LOLA).

When should I take it?
Timing matters less than consistency. Pick a time that works for you and take it daily.
Can I take it with other supplements?
Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
Any side effects to watch for?
Most people tolerate it well at recommended doses. GI upset is the most common complaint with any supplement. Start with a lower dose and work up. If something feels off, stop and reassess.
Who benefits most from this?
People who've already covered the basics (diet, sleep, exercise) and want to fine-tune. It's not essential, but could be worthwhile for the right person.
Pairs well with25 on file

Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.

Ornithine is one of the two amino acids in the salt and is the carrier that accepts a carbamoyl group in the urea cycle. Adding free ornithine raises the same pool the salt delivers.

Aspartate is the second amino acid in the salt and donates the second nitrogen atom to urea via argininosuccinate synthetase. It is a direct substrate of the same cycle.

Arginase splits arginine into urea and ornithine, so arginine both feeds and regenerates the ornithine pool. The two sit one step apart on the same cycle.

Citrulline is formed when ornithine takes on a carbamoyl group and then condenses with aspartate. It sits directly between the two amino acids in this salt.

Glutamine synthetase in muscle binds free ammonia onto glutamate to make glutamine, the body's main nitrogen shuttle. Ornithine supplies glutamate carbon through its transamination, linking the two routes for handling nitrogen.

The first and third steps of the urea cycle consume ATP, which is used as a magnesium complex. Magnesium status therefore sets the pace of the cycle these amino acids feed.

Branched-chain amino acids donate their amino group to glutamate in muscle, feeding glutamine synthesis. That is the same nitrogen route the ornithine half of the salt supports.

OKG delivers ornithine with alpha-ketoglutarate as the counter-ion instead of aspartate. Both raise ornithine and both supply a carbon skeleton that feeds glutamate.

Ornithine aminotransferase and aspartate aminotransferase are both pyridoxal-phosphate enzymes. Without adequate B6 neither amino acid moves onward efficiently.

Biotin-dependent pyruvate carboxylase replenishes oxaloacetate, the precursor of aspartate. Aspartate supply is one limb of the reaction this salt drives.

L-Ornithine L-Aspartate (LOLA) + ZincEstablished enzymology of the urea cycle

Ornithine transcarbamylase and other urea cycle enzymes depend on adequate zinc status, and low zinc is a recognised limiter of urea synthesis capacity. Supplying ornithine as substrate does little if the enzyme handling it is constrained. This is enzymology rather than a tested combination.

L-Ornithine L-Aspartate (LOLA) + ManganeseEstablished metalloenzyme biochemistry

Arginase, the enzyme that closes the urea cycle by splitting arginine into urea and ornithine, is a manganese metalloenzyme with two manganese ions in its active site. Ornithine is literally the product of that reaction. The cofactor relationship is textbook and needs no trial.

L-Ornithine L-Aspartate (LOLA) + L-prolineEstablished amino acid interconversion

Ornithine aminotransferase converts ornithine to glutamate semialdehyde, which cyclises and is reduced to proline, and the same route runs in the other direction. Ornithine and proline are therefore two steps apart in a single pathway. This matters for connective tissue formulas where proline supply is the point.

L-Ornithine L-Aspartate (LOLA) + SpermidineEstablished polyamine biochemistry

Ornithine decarboxylase removes the carboxyl group from ornithine to make putrescine, the committed first step of polyamine synthesis, and putrescine is then built up to spermidine and spermine. Ornithine is the entry point to that whole family. Established biochemistry, stated as a pathway relationship and not as an effect claim.

The first step of creatine synthesis transfers the guanidino group from arginine to glycine, producing guanidinoacetate and releasing ornithine as the other product. Ornithine and creatine synthesis therefore sit on the same reaction. The link is biochemical rather than a demonstration that one supports the other in practice.

L-Ornithine L-Aspartate (LOLA) + GlycineEstablished biosynthetic pathway

Glycine is the acceptor in the arginine:glycine amidinotransferase reaction that releases ornithine, so the two sit on either side of one enzyme. Glycine is also a substrate for glutathione and collagen, both of which draw on the same amino acid pool. Read this as pathway adjacency, not as a combination effect.

L-Ornithine L-Aspartate (LOLA) + ProbioticsA randomised comparison that included both approaches

A randomised trial compared this compound against probiotics and against an antibacterial agent for their effect on circulating ammonia and neuropsychometric measures, so the two are studied against the same endpoint by different routes. Probiotics act on how much ammonia is generated and absorbed in the gut, while the amino acid salt acts on how ammonia is disposed of in liver and muscle. The endpoints in that work are measured markers and test scores in a clinical population.

L-Ornithine L-Aspartate (LOLA) + Lactobacillus plantarumMechanistic overlap with the gut nitrogen route

Urease-negative lactic acid bacteria lower colonic pH through fermentation, which shifts ammonia toward the charged ammonium form that crosses the gut wall less readily. That reduces the nitrogen load reaching the liver, where ornithine and aspartate act. The two approaches address different ends of the same pathway and have not been tested together as a pair.

L-Ornithine L-Aspartate (LOLA) + Bifidobacterium longumMechanistic overlap with the gut nitrogen route

Bifidobacteria ferment carbohydrate to short-chain fatty acids and acidify the colonic lumen, which traps ammonia as ammonium and lowers what is absorbed. Ornithine and aspartate work downstream on nitrogen disposal. The pairing is mechanistically complementary and clinically untested as a combination.

L-Ornithine L-Aspartate (LOLA) + L-valineEstablished branched-chain amino acid nitrogen handling

Branched-chain amino acids donate nitrogen to alpha-ketoglutarate in muscle to form glutamate, which glutamine synthetase then combines with free ammonia to make glutamine. Ornithine drives the same muscle glutamine route by supplying glutamate. Both are studied in the same clinical space, and combination data for the pair is limited.

L-Ornithine L-Aspartate (LOLA) + L-carnitineOverlapping study areas, distinct mechanisms

Carnitine shuttles long-chain fatty acids into mitochondria and has been studied for its effect on circulating ammonia in exercise settings, an endpoint this compound is also studied against. The routes are different: one is fatty acid transport, the other is urea cycle substrate supply. The overlap is in the marker measured, not in the mechanism.

L-Ornithine L-Aspartate (LOLA) + NACEstablished sulphur amino acid biochemistry

N-acetylcysteine supplies cysteine for glutathione synthesis, which supports hepatic handling of reactive intermediates while ornithine and aspartate supply urea cycle substrate. The two support different aspects of liver metabolism and are sometimes formulated together. The pairing rests on mechanism, and no combination trial grounds it.

Silymarin is the most common botanical in formulas aimed at normal liver function, and this amino acid salt is the most common amino acid one, so they turn up in the same products. Their mechanisms do not overlap: one is a flavonolignan antioxidant, the other a urea cycle substrate pair. This is formulation convention, not a demonstrated combination.

L-Ornithine L-Aspartate (LOLA) + L-methionineEstablished nitrogen metabolism

Methionine catabolism generates ammonia through the transsulphuration and downstream pathways, adding to the nitrogen load that the urea cycle handles. A high methionine intake therefore works against the direction ornithine and aspartate push. The interaction is at the level of substrate load and is not quantified for supplement doses.

L-Ornithine L-Aspartate (LOLA) + TrimethylglycineEstablished one-carbon and nitrogen biochemistry

Betaine remethylates homocysteine to methionine, which feeds back into the methionine pool whose breakdown releases nitrogen for urea synthesis. It also acts as an organic osmolyte in liver cells. The connection is indirect and drawn from pathway biochemistry rather than from combination research.

Who should be cautious

Nothing specific on file for L-Ornithine L-Aspartate (LOLA). Match the label to the daily amount above, and tell your doctor what you take.

Not medical advice. Show the label to your pharmacist.

What L-Ornithine L-Aspartate (LOLA) actually does.

Established

L-ornithine L-aspartate is a one-to-one salt of two amino acids, and both halves are substrates of the urea cycle rather than inert carriers for each other.

Established

Ornithine is the acceptor molecule of the urea cycle: ornithine transcarbamylase joins it to carbamoyl phosphate to form citrulline, and ornithine is regenerated at the end of the cycle when arginase splits arginine.

Established

Aspartate donates the second of the two nitrogen atoms that end up in urea, through argininosuccinate synthetase, so the two amino acids in this salt feed different entry points of the same cycle.

Established

Ornithine also supplies glutamate through ornithine aminotransferase, and glutamine synthetase in skeletal muscle combines glutamate with free ammonia to form glutamine, which is a second route for handling circulating nitrogen alongside hepatic urea synthesis.

More than one route, 6 steps on record

Where L-Ornithine L-Aspartate (LOLA) comes from.

Two amino acids get made separately and then joined into one compound. Bacteria fed on sugar produce the ornithine; an enzyme adds ammonia to a simple acid to produce the aspartic acid. Both are cleaned up and crystallised, then mixed in water in equal amounts so they bond into a single salt, which is dried into powder for sachets or tablets.

The same molecule is reached more than one way. Which route a given product used is a manufacturing choice, and the finished compound is the same either way.

Starts as
Glucose from starch hydrolysis

Both amino acids trace back to a fermentable sugar feedstock, typically glucose from corn or cassava starch, plus an ammonia or ammonium nitrogen source.

Converted by
Microbial fermentation to L-ornithine

L-ornithine is produced by fed-batch fermentation with Corynebacterium glutamicum strains engineered for arginine-pathway flux, which yields the L form directly with no resolution step.

Converted by
Enzymatic or fermentative route to L-aspartic acid

L-aspartic acid is commonly made by adding ammonia across fumaric acid using immobilised aspartase from a bacterial source, a single-step reaction that gives the L isomer.

Purified by
Ion exchange and crystallisation of each amino acid

Each broth or reaction liquor is clarified, passed over ion exchange resin to separate the amino acid from salts and residual substrate, then crystallised and dried.

Converted by
Salt formation

The purified free base ornithine and free acid aspartate are combined in aqueous solution at a controlled one-to-one molar ratio, so the product is a formed salt rather than a physical blend.

Ends up as
Drying, granulation and packing

The salt solution is dried and granulated into sachet material, or milled and blended for tabletting; batches are assayed for optical rotation, identity and residual solvent.

Getting L-Ornithine L-Aspartate (LOLA) from food.

The whole-food sources on file. A supplement closes the gap, it does not replace dinner.

Beef (lean)Chicken breastFish

A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.

The forms it comes in.

LOLA granules for oral solutionA stoichiometric salt of L-ornithine and L-aspartic acid dissolved to a solution before drinking, so the two amino acids arrive in a fixed ratioFits Divided daily dosing where the intended ratio matters and a measured sachet is easier than counting capsulesTrade-off The taste is strongly acidic and amino acid heavy, and the sachet has to be dissolved rather than swallowed dry
LOLA tabletsThe same salt compressed or encapsulated, usually with binders and a flow agentFits Fixed portable dosing without preparing a solutionTrade-off Gram-level daily amounts mean several units per dose, and the excipient load rises with the tablet countActive and formulation aid
Free amino acid blend, not the saltThe two amino acids supplied separately in one product rather than as a formed salt, so the ratio depends on the formulator and the ornithine is usually the hydrochlorideFits Formulas that want to set an ornithine amount independently of aspartate, or to add other amino acids alongsideTrade-off It is a different article from the one-to-one salt studied in the clinical literature, and the label rarely makes that distinction clearActive and formulation aid
LOLA intravenous concentrateThe same salt in a sterile aqueous concentrate for dilution and infusion under clinical supervisionFits Hospital use where oral intake is not possible; listed here because much of the published literature uses this routeTrade-off Not a supplement format and not comparable to oral dosing, so results obtained by infusion do not transfer to a capsule
What the strongest studies found

The essence, in one line each.

  1. Across human studies in healthy adults, oral L-ornithine at the doses studied was well tolerated, with no consistent pattern of adverse effects reported.Systematic review. Yang et al., 2025 (Amino acids). PMID 40323503
  2. A systematic review assessed whether ammonia-lowering with L-ornithine L-aspartate changes measured outcomes in adults with elevated liver fat, and set out what the evidence base does and does not support.Systematic review. Ismaiel et al., 2026 (European Journal of Clinical Investigation). PMID 41653037
  3. A Cochrane review pooled randomised trials of L-ornithine L-aspartate in adults with chronic liver impairment and judged the certainty of the pooled evidence, noting limitations in trial quality and size.Systematic review. Goh et al., 2018 (Cochrane Database of Systematic Reviews). PMID 29762873
  4. A randomised comparison of an antibacterial agent, probiotics and L-ornithine L-aspartate against placebo on neuropsychometric test performance and circulating ammonia in adults with chronic liver impairment; the endpoints are test scores and a blood marker.Randomised trial. Sharma et al., 2014 (Saudi Journal of Gastroenterology). PMID 25038208
  5. Frailty biomarkers were tracked in adults receiving a multi-component intervention in which L-ornithine L-aspartate was one element; because several components moved together, no result can be attributed to this ingredient alone.Open-label trial. Laghi et al., 2024 (Biomolecules). PMID 39595586
  6. Reviewed urea cycle and arginine pathway biology in the setting of elevated liver fat, describing where ornithine and aspartate sit in nitrogen handling; a mechanistic review, not a source of clinical effect estimates.Narrative review. Zhu et al., 2026 (International Journal of Molecular Medicine). PMID 42272250
  7. Metabolomic profiling linked aspartate availability to immune response measures and survival in a mouse model of severe infection; an animal model, and aspartate appears as a metabolite rather than as a supplement given.Animal study. Lee et al., 2026 (Cells). PMID 41892305
  8. Enhancing hepatic ammonia detoxification altered the liver microenvironment in the models studied, supporting the general idea that ureagenesis capacity shapes hepatic biology; mechanistic animal and cell work in an oncology context, with the ingredient named only within that broader mechanism.Animal study. Sun et al., 2026 (Advanced Science). PMID 41933927

These are the studies our verdict leans on, chosen from the 122 we read for L-Ornithine L-Aspartate (LOLA). The full linked list is below.

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.